Description |
Valerenic acid ((-)-Valerenic Acid), a sesquiterpenoid, is an orally active positive allosteric modulator of GABAA receptors. Valerenic acid is also a partial agonist of the 5-HT5a receptor. Valerenic acid mediates anxiolytic activity via GABAA receptors containing the β3 subunit. Valerenic acid also exhibits potent antioxidant properties[1][2][3].
|
Target |
5-HT5A Receptor:17.2 μM (IC50)
GABAA
|
In Vitro |
Valerenic acid (1-100 μM) enhances the whole cell currents on GABAA receptors expressed in HEK 293 cells[1]. Valerenic acid exhibits significant affinity for the 5-HT5a receptor, with an IC50 of 17.2 μM (Ki=10.7 μM)[2]. [3H]Valerenic acid binds to brain membranes reveals both a high affinity binding site (KD=25 nM) and a low affinity site (KD=16 μM)[1]. [3H]Valerenic acid is displaced by Valerenol with high potency (IC50=3 nM)[1].
|
In Vivo |
Valerenic acid (1-6 mg/kg i.p. or 10 mg/kg p.o.) decreases the aversion of wild type mice to the lit area[2]. Valerenic acid (10 mg/kg; p.o.) increases the proportion of time 129X1/SvJ mice spent onto the open arms[2].
|
Density | 1.1±0.1 g/cm3 |
Boiling Point | 374.5±21.0 °C at 760 mmHg |
Flash Point | 274.2±13.0 °C |
Exact Mass | 234.161987 |
PSA | 37.30000 |
LogP | 5.13 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Storage condition | −20°C |